C-MORAL: Controllable Multi-Objective Molecular Optimization with Reinforcement Alignment for LLMs
Not on the map. Why?
Abstract (arXiv)
Large language models (LLMs) show promise for molecular optimization, but aligning them with selective and competing drug-design constraints remains challenging. We propose C-Moral, a reinforcement learning post-training framework for controllable multi-objective molecular optimization. C-Moral combines group-based relative optimization, property score alignment for heterogeneous objectives, and bottleneck-sensitive non-linear reward aggregation to improve stability across competing molecular properties. Experiments on C-MuMOInstruct and S2-Bench MolOpt show that C-Moral achieves the best performance among compared methods on both benchmarks. On C-MuMOInstruct, C-Moral achieves the best Success Optimized Rate (SOR) of 48.9% on in-domain tasks and 39.5% on out-of-domain tasks while preserving scaffold similarity. On S2-Bench MolOpt, it also achieves the strongest results across LogP, MR, and QED optimization tasks. These results suggest that C-Moral is an effective way to align molecular LLMs with continuous and constrained molecular design objectives. Our code and models are publicly available at https://github.com/Rwigie/C-MORAL.
Key facts. No citing papers in the map yet (data through 14 Oct 2026). Builds on 20 of its 38 references that are in the map. First posted on arXiv 24 Apr 2026.
Builds on
20 of 38 references.
References · 20
- 2021LoRA: Low-Rank Adaptation of Large Language Modelscited by 14,380
- 2023LLaMA: Open and Efficient Foundation Language Modelscited by 14,132
- 2024DeepSeekMath: Pushing the Limits of Mathematical Reasoning in Open Language Modelscited by 9,379
- 2024HybridFlow: A Flexible and Efficient RLHF Frameworkcited by 2,057
- 2016Automatic chemical design using a data-driven continuous representation of moleculescited by 765
- 2018GuacaMol: Benchmarking Models for De Novo Molecular Designcited by 297
- 2017Molecular De Novo Design through Deep Reinforcement Learningcited by 267
- 2018Optimization of Molecules via Deep Reinforcement Learningcited by 200
- 2026GDPO: Group reward-Decoupled Normalization Policy Optimization for Multi-reward RL Optimizationcited by 193
- 2023What can Large Language Models do in chemistry? A comprehensive benchmark on eight taskscited by 185
- 2023DrugAssist: A Large Language Model for Molecule Optimizationcited by 59
- 2023ChatGPT-powered Conversational Drug Editing Using Retrieval and Domain Feedbackcited by 31
8 more
- 2024DecompOpt: Controllable and Decomposed Diffusion Models for Structure-based Molecular Optimizationcited by 27
- 2024LICO: Large Language Models for In-Context Molecular Optimizationcited by 26
- 2025LIDDIA: Language-based Intelligent Drug Discovery Agentcited by 24
- 2024LLaMo: Large Language Model-based Molecular Graph Assistantcited by 22
- 2023Searching for High-Value Molecules Using Reinforcement Learning and Transformerscited by 18
- 2024Mol-AIR: Molecular Reinforcement Learning with Adaptive Intrinsic Rewards for Goal-directed Molecular Generationcited by 7
- 2026Reference-guided Policy Optimization for Molecular Optimization via LLM Reasoningcited by 6
- 2025Large Language Models for Controllable Multi-property Multi-objective Molecule Optimizationcited by 2
Built on by
Not cited yet.
Similar, not cited
Close in wording, no citation either way
- 2026MFG: Multi-turn Feedback Guided Molecular Optimization
- 2026Scaffold-Conditioned Preference Triplets for Controllable Molecular Optimization with Large Language Models
- 2026Adopting Reinforcement Learning with Verifiable Rewards for Molecular Generation
- 2026MARCO: Multi-Round Agentic Reinforcement for Conditional Molecular Optimization
- 2025MT-Mol:Multi Agent System with Tool-based Reasoning for Molecular Optimization
- 2026DrugR: Optimizing Molecular Drugs through LLM-based Explicit Reasoning
- 2025Collaborative Expert LLMs Guided Multi-Objective Molecular Optimization
- 2026Evaluating the Progression of Large Language Model Capabilities for Small-Molecule Drug Design